APH.TO - Aphria Inc.

Toronto - Toronto Delayed Price. Currency in CAD
13.47
+0.42 (+3.22%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close13.05
Open13.26
Bid13.47 x 0
Ask13.49 x 0
Day's Range13.15 - 13.58
52 Week Range4.06 - 14.89
Volume2,663,133
Avg. Volume3,107,506
Market Cap2.042B
BetaN/A
PE Ratio (TTM)94.20
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • CNW Group2 days ago

    S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

    Results of the Quarterly Review of the S&P/TSX Composite Index TORONTO , Dec. 8, 2017 /CNW/ - S&P Dow Jones Canadian Index Services will make the following changes in the S&P/TSX Canadian Indices prior ...

  • CNW Group6 days ago

    IIROC Trade Resumption - APH

    TORONTO , Dec. 4, 2017 /CNW/ - Trading resumes in: Company: Aphria Inc. TSX Symbol: APH Resumption (ET): 4:30 PM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security ...

  • PR Newswire6 days ago

    IIROC Trade Resumption - APH

    TORONTO , Dec. 4, 2017 /CNW/ - Trading resumes in: Company: Aphria Inc. TSX Symbol: APH Resumption (ET): 4:30 PM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security ...

  • PR Newswire6 days ago

    IIROC Trading Halt - APH

    TORONTO , Dec. 4, 2017 /CNW/ - The following issues have been halted by IIROC: Company: Aphria Inc. TSX Symbol: APH (all issues) Reason: Pending News Halt Time (ET): 3:48 PM IIROC can make a decision to ...

  • CNW Group6 days ago

    IIROC Trading Halt - APH

    TORONTO , Dec. 4, 2017 /CNW/ - The following issues have been halted by IIROC: Company: Aphria Inc. TSX Symbol: APH (all issues) Reason: Pending News Halt Time (ET): 3:48 PM IIROC can make a decision to ...

  • PR Newswire6 days ago

    Aphria enters into supplier agreement with Shoppers Drug Mart

    LEAMINGTON, ON, Dec. 4, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart. Subject to Health Canada's approval of Shoppers Drug Mart's application to be a licensed producer, under the terms of the agreement the Company will supply Shoppers Drug Mart with Aphria-branded medical cannabis products. It is expected the products will be sold online, as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.

  • CNW Group6 days ago

    Aphria enters into supplier agreement with Shoppers Drug Mart

    LEAMINGTON, ON, Dec. 4, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart. Subject to Health Canada's approval of Shoppers Drug Mart's application to be a licensed producer, under the terms of the agreement the Company will supply Shoppers Drug Mart with Aphria-branded medical cannabis products. It is expected the products will be sold online, as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.

  • Newsfile6 days ago

    IIROC Trade Halt - Aphria Inc.

    Toronto, Ontario--(Newsfile Corp. - December 4, 2017) - The following issues have been halted by IIROC: Company:  Aphria Inc. TSX Symbol: APH (all issues) ...

  • Tokyo Smoke wins Best Brand at inaugural Canadian Cannabis Awards
    Marketwired6 days ago

    Tokyo Smoke wins Best Brand at inaugural Canadian Cannabis Awards

    Tokyo Smoke, a leading cannabis lifestyle brand, was awarded Brand of the Year at the inaugural Canadian Cannabis Awards gala, held on Nov. 30 in Toronto. The prestigious award recognizes Tokyo Smoke's ...

  • Tokyo Smoke announces President, VP of Strategy and Marketing, Head of Content
    Marketwired11 days ago

    Tokyo Smoke announces President, VP of Strategy and Marketing, Head of Content

    Tokyo Smoke is pleased to announce the appointment of Brian Polsinello as President, alongside Felicia Snyder as Vice President, Strategy and Marketing, and Odessa Paloma Parker as Head of Content, joining ...

  • ACCESSWIRE11 days ago

    Today’s Research Reports on Acerus Pharmaceuticals, Aphria Inc., Oncolytics Biotech Inc. and GLG Life Tech Corporation

    NEW YORK, NY / ACCESSWIRE / November 29, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • PR Newswire17 days ago

    Aphria Achieves Next Milestone in International Expansion Strategy with Receipt of Dealer's License

    LEAMINGTON, ON, Nov. 23, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) achieved another milestone as part of its expansion strategy, obtaining its Dealer's License pursuant to the Controlled Drugs and Substances Act under Health Canada.  This permits the Company to possess, sell and transport medical cannabis oil and resin to international markets. "There is an incredible appetite for high-quality medical cannabis in legal markets around the world.

  • CNW Group17 days ago

    Aphria Achieves Next Milestone in International Expansion Strategy with Receipt of Dealer's License

    LEAMINGTON, ON, Nov. 23, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) achieved another milestone as part of its expansion strategy, obtaining its Dealer's License pursuant to the Controlled Drugs and Substances Act under Health Canada.  This permits the Company to possess, sell and transport medical cannabis oil and resin to international markets.

  • Tokyo Smoke Beltline in Calgary opens December 7
    Marketwired19 days ago

    Tokyo Smoke Beltline in Calgary opens December 7

    Tokyo Smoke continues its ambitious national retail expansion by announcing that the Calgary, Alberta retail location will open Thurs., Dec. 7, marking the brand's first shop outside of Ontario. Tokyo ...

  • CNW Group25 days ago

    Alternate Health Acquires Cannabis Blockchain Point-of-Sale and Payment Software Solution

    TORONTO, Nov. 15, 2017 /CNW/ - Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTC:AHGIF - News), an international, vertically-integrated medical cannabis company, today announced the acquisition a new Mobile Payment Processing Application, acting as turnkey payment solution and point-of-sale technology with comprehensive Blockchain reporting. "This acquisition is the final piece needed to fully integrate Alternate Health's cannabis-specific Electronic Medical Records (EMR) and Transaction Management software with Blockchain technology," says Dr. Michael Murphy, CEO of Alternate Health.

  • CNW Grouplast month

    Aphria Announces Closing of Bought Deal Financing

    LEAMINGTON, ON, Nov. 7, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB:  APHQF) is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option.  A total of 12,689,675 common shares (the "Shares") of the Company were sold at a price of $7.25 per Share, for aggregate gross proceeds of $92,000,144 (the "Offering").  The Offering was underwritten by a syndicate of underwriters led by Clarus Securities Inc. and included Cormark Securities Inc., Canaccord Genuity Corp. and PI Financial Corp (collectively, the "Underwriters").

  • CNW Grouplast month

    Alternate Health launches new alternatehealth.com domain, prepares for further U.S. expansion with appearance at Ethereum's Devcon3 conference

    TORONTO, Nov. 1, 2017 /CNW/ - Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTC:AHGIF - News), an international, vertically-integrated medical cannabis company, today announced a renewed focus on the U.S. market with the launch of the new alternatehealth.com domain while confirming attendance at Devcon3, hosted by Ethereum, a Blockchain protocol whose value skyrocketed from $72 million to $28 billion in just 2017. "Alternate Health is growing in momentum across all of our verticals, boosting our visibility in the American medical cannabis market," says Dr. Michael Murphy, CEO of Alternate Health.

  • PR Newswirelast month

    Shareholders elect Renah Persofsky and Shawn Dym to Aphria's Board of Directors

    LEAMINGTON, ON, Oct. 27, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB:  APHQF) is pleased to announce that Renah Persofsky and Shawn Dym were elected as new directors at the Company's annual general and special meeting held on October 25, 2017. Mr. Dym is a managing director at York Plains Investment Corp., a private investment vehicle focused on maximizing absolute returns by investing in a wide array of asset classes, including successful cannabis related investments.  He currently serves on the board of advisors for Green Acre Capital, Canada's first private investment fund focused on the cannabis industry, as well as the board of directors at Wellpoint Health and Totally Green. "We are pleased to welcome Renah and Shawn to Aphria's Board of Directors.  Together, they bring valuable  capital markets and cannabis industry expertise that will be instrumental in driving Aphria's strategic direction as a global leader in the cannabis industry.  Their passion for success in growing dynamic companies will be a tremendous asset to the board," said Vic Neufeld, Chief Executive Officer of Aphria.

  • CNW Grouplast month

    Shareholders elect Renah Persofsky and Shawn Dym to Aphria's Board of Directors

    LEAMINGTON, ON, Oct. 27, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB:  APHQF) is pleased to announce that Renah Persofsky and Shawn Dym were elected as new directors at the Company's annual general and special meeting held on October 25, 2017. Mr. Dym is a managing director at York Plains Investment Corp., a private investment vehicle focused on maximizing absolute returns by investing in a wide array of asset classes, including successful cannabis related investments.  He currently serves on the board of advisors for Green Acre Capital, Canada's first private investment fund focused on the cannabis industry, as well as the board of directors at Wellpoint Health and Totally Green. "We are pleased to welcome Renah and Shawn to Aphria's Board of Directors.  Together, they bring valuable  capital markets and cannabis industry expertise that will be instrumental in driving Aphria's strategic direction as a global leader in the cannabis industry.  Their passion for success in growing dynamic companies will be a tremendous asset to the board," said Vic Neufeld, Chief Executive Officer of Aphria.

  • Marketwired2 months ago

    Tokyo Smoke closes on upsized $6 million Series B round

    Tokyo Smoke, an award-winning lifestyle brand that brings sophistication and design to the cannabis space, is pleased to confirm the final closing of its oversubscribed Series B funding of approximately ...

  • PR Newswire2 months ago

    Aphria Completes First Medical Cannabis Oil (CBD/THC) Shipment to Australia-based Medlab

    LEAMINGTON, ON, Oct. 24, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF), announced today that it completed its first shipment of cannabis oil to Australian medical life science company, Medlab Clinical Limited (ASX:MDC). The shipment is part of the previously announced agreement between Aphria and Medlab, in which Aphria will produce and supply high-yield cannabis extracts for Medlab to be used in its forthcoming human trial to test management of intractable pain in oncology patients – the first trial of its kind globally.

  • CNW Group2 months ago

    Aphria Completes First Medical Cannabis Oil (CBD/THC) Shipment to Australia-based Medlab

    LEAMINGTON, ON, Oct. 24, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF), announced today that it completed its first shipment of cannabis oil to Australian medical life science company, Medlab Clinical Limited (ASX:MDC). The shipment is part of the previously announced agreement between Aphria and Medlab, in which Aphria will produce and supply high-yield cannabis extracts for Medlab to be used in its forthcoming human trial to test management of intractable pain in oncology patients – the first trial of its kind globally.

  • UPDATE - Van der Pop to launch branded cannabis with WeedMD in November 2017
    Marketwired2 months ago

    UPDATE - Van der Pop to launch branded cannabis with WeedMD in November 2017

    Van der Pop , North America's leading female-focused cannabis brand, is pleased to announce its two branded strains of cannabis will be available for purchase by the end of November, in partnership with ...

  • Marketwired2 months ago

    Aphria Inc. Announces $80 Million Bought Deal

     NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. is pleased to announce that it has entered into an agreement with Clarus Securities Inc.,...

  • PR Newswire2 months ago

    Aphria welcomes new CSA disclosure guidelines, provides comment on TSX staff notice

    LEAMINGTON, ON, Oct. 17, 2017 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH or USOTCQB: APHQF) responded today to both the Canadian Securities Administrators ("CSA") Staff Notice 51-352 – Issuers with U.S. Marijuana-Related Activities and the Toronto Stock Exchange ("TSX") guidance on Section 306, Section 325 and Part VII of the TSX Company Manual, issued on October 16, 2017.